⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2432407 | 0.74 | — | — | |
| SCHEMBL2227082 | 0.72 | — | — | |
| SCHEMBL400697 | 0.70 | — | — | |
| SCHEMBL8323712 | 0.70 | — | — | |
| SCHEMBL10667404 | 0.70 | — | — | |
| SCHEMBL472918 | 0.70 | — | — | |
| SCHEMBL3291481 | 0.68 | — | — | |
| SCHEMBL3664471 | 0.65 | — | — | |
| SCHEMBL535011 | 0.65 | — | — | |
| SCHEMBL1199564 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4782363-B2 | — | — | 2011-09-28 | — | — | JP | claimed |
| EP-1352005-B1 | SUPRAMOLECULAR POLYMER FORMING POLYMER | HUNTSMAN INT LLC (US) | 2008-10-29 | — | — | EP | claimed |
| US-7390446-B2 | fine cell structure, very good surface appearance, a relatively thin skin; As H-bridge-forming monomeric units, substituted ureido-pyrimidones and ureido-pyrimidines were used | HUNTSMAN INTERNATIONAL LLC (US) | 2008-06-24 | — | — | US | claimed |
| EP-1332132-B1 | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES | UCB PHARMA SA (BE) | 2007-10-10 | — | — | EP | claimed |
| CN-1331924-C | Foamed supramolecular polymers | HUNTSMAN INT LLC (US) | 2007-08-15 | — | — | CN | claimed |
| CN-1326900-C | Supramolecular polymer-forming polymers | HUNTSMAN INT LLC (US) | 2007-07-18 | — | — | CN | claimed |
| US-20070149751-A1 | Bulk manufacturing of supramolecular polymer forming polymer | LINDSAY CHRISTOPHER I | 2007-06-28 | — | — | US | claimed |
| EP-1511794-B1 | FOAMED SUPRAMOLECULAR POLYMERS | HUNTSMAN INT LLC (US) | 2007-05-02 | — | — | EP | claimed |
| CN-1656157-A | Foamed supramolecular polymers | HUNTSMAN INT LLC (US) | 2005-08-17 | — | — | CN | claimed |
| US-20050151291-A1 | Foamed supramolecular polymers | HUNTSMAN INTERNATIONAL LLC | 2005-07-14 | — | — | US | claimed |
| CN-1479759-A | Supramolecular polymer forming polymer | — | 2004-03-03 | — | — | CN | claimed |
| US-20030229116-A1 | ENAMINE DERIVATIVES | UCB PHARMA S.A. (BE) | 2003-12-11 | — | — | US | claimed |
| WO-2003099875-A2 | FOAMED SUPRAMOLECULAR POLYMERS | HUNTSMAN INTERNATIONAL LLC (US) | 2003-12-04 | — | — | WO | claimed |
| EP-1352005-A1 | SUPRAMOLECULAR POLYMER FORMING POLYMER | HUNTSMAN INTERNATIONAL LLC (US) | 2003-10-15 | — | — | EP | claimed |
| US-6610700-B2 | Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example | CELLTECH R & D LIMITED (GB) | 2003-08-26 | — | — | US | claimed |
| EP-1332132-A2 | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES | Celltech R&D Limited (GB) | 2003-08-06 | — | — | EP | claimed |
| WO-2002046260-A1 | SUPRAMOLECULAR POLYMER FORMING POLYMER | HUNTSMAN INTERNATIONAL LLC (US) | 2002-06-13 | — | — | WO | claimed |
| EP-1213309-A1 | Supramolecular polymer forming polymer | HUNTSMAN INTERNATIONAL LLC (US) | 2002-06-12 | — | — | EP | claimed |
| US-20020037909-A1 | Enamine derivatives | UCB PHARMA S.A. (BE) | 2002-03-28 | — | — | US | claimed |
| WO-2001079173-A2 | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES | CELLTECH R & D LIMITED (GB) | 2001-10-25 | — | — | WO | claimed |